Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer ; volume:17 ; number:1 ; day:28 ; month:9 ; year:2024 ; pages:1-18 ; date:12.2024
Journal of ovarian research ; 17, Heft 1 (28.9.2024), 1-18, 12.2024
- Creator
-
Chen, Shuo-Fu
Wang, Liang-Yun
Lin, Yi-Sian
Chen, Cho-Yi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-024-01518-w
- URN
-
urn:nbn:de:101:1-2412142119027.178886127170
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Shuo-Fu
- Wang, Liang-Yun
- Lin, Yi-Sian
- Chen, Cho-Yi
- SpringerLink (Online service)
Other Objects (12)
Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
Immunotherapeutic approaches to ovarian cancer treatment
An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides
Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
Protein-based biopolymers
Identification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma
Patterning of protein‐based materials
Immunotherapeutic advances in gastrointestinal malignancies
Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
Immunotherapeutic approaches to ovarian cancer treatment
An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides
Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
Protein-based biopolymers
Identification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma
Patterning of protein‐based materials
Immunotherapeutic advances in gastrointestinal malignancies
Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
Immunotherapeutic approaches to ovarian cancer treatment
An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides
Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
Protein-based biopolymers
Identification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma
Patterning of protein‐based materials